DiaMedica Therapeutics, Inc. (DMAC) vs ProKidney Corp. (PROK)
- DiaMedica Therapeutics, Inc. DMAC 7.57 −5.85%
- ProKidney Corp. PROK 1.33 −8.90%
DiaMedica Therapeutics, Inc. and ProKidney Corp. are both Biotechnology companies. DiaMedica Therapeutics, Inc. and ProKidney Corp. are of similar size ($439.9M and $433.6M). DiaMedica Therapeutics, Inc. has the higher net margin (0.00% vs −10,288.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, DiaMedica Therapeutics, Inc. leads on 6 and ProKidney Corp. on 5.
Valuation
Profitability
| Metric | DMAC | PROK | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (21,664.55%) | 0.00% |
| Net margin | 0.00% | (10,288.39%) | 0.00% |
| Free cash flow margin | 0.00% | (17,300.61%) | 0.00% |
| Return on equity | (114.62%) | 8.92% | (56.36%) |
| Return on assets | (98.18%) | (27.10%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack